Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
MaxoCum
- Development stage
- Unknown
- Lead developer
- Vitofarma
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
MaxoCum is an herbal dietary supplement developed by Vitofarma, specifically formulated to enhance male reproductive health and improve sperm quality. The product is designed to increase semen volume, sperm count, and motility. Its formulation typically consists of a proprietary blend of traditional medicinal herbs known for their aphrodisiac and spermatogenic properties, including *Mucuna pruriens*, *Withania somnifera* (Ashwagandha), and *Tribulus terrestris*. These ingredients are thought to work synergistically by modulating the hypothalamic-pituitary-gonadal (HPG) axis to support healthy testosterone levels, reducing oxidative stress within the reproductive system, and managing cortisol levels to mitigate the negative impact of stress on spermatogenesis. *Mucuna pruriens* is a notable component as it contains L-Dopa, a precursor to dopamine that can influence the secretion of hormones relevant to male fertility.
- Brand names
- MaxoCum
02
Targets
DRD (Dopamine receptors)GR (Glucocorticoid receptor)AR (Adrenergic receptors)
Beyond the preview
Go deeper on MaxoCum.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on MaxoCum.